baber/WOPTO huggingface dataset:
Patent CA-2498435-A1 (CA)
Inventor: HIEBERT DAVID B
IPC: A47L9/02
Filed: 2005-02-25
Abstract: A vacuum system with a blower, a flexible hose connected to an intake opening and a discharge duct for transporting the materials to a collection zone has a suction nozzle mounted on the outer end of the flexible hose. The nozzle is formed by a cylindrical collar connected to the outer end of the flexible hose, a pick-up tube mounted within the collar so as to define an annular space therebetween and projecting forwardly from the forward end of the collar to an open circular mouth into which material to be picked up can be drawn to enter the pick-up tube to be transported by the hose to the blower for discharge to the collection zone.
Patent CA-2505783-A1 (CA)
Title: The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence
Inventor: WONG ERIK HO FONG
IPC: A61K31/47
Filed: 2003-11-20
Abstract: Provided herein are methods of using compounds of formula (IA-IF) that are aryl- and heteroaryl-substituted tetrahydroisoquinolines, for the treatment of chronic and neuropathic pain, the treatment and prevention of migraine headache, and the treatment of stress, urge and mixed urinary incontinence.< /SDOAB>
Patent CA-2508540-A1 (CA)
Title: Creation and management of content-related objects
Inventor: MILLER PATRICK C
IPC: G06F17/30
Filed: 2005-05-27
Abstract: A web content management server allows for the automatic creation, management and publication of variant objects from a parent object. The variant object is created as a copy of the corresponding parent object and may then be:  modified. Each object includes a pages list that identifies all associated objects and the content type of each object listed in the pages list. The relationship between parent end variant objects is maintained regardless of the location where the objects are stored. When changes are made to the parent page, the changes are also implemented in any corresponding variant pages. The parent object tracks any corresponding variant objects with an identifier stored in the pages list. When the parent page is modified, a workflow is triggered to modify the corresponding variant pages identified by the identifier and the content type in the pages list.
Patent CA-2509926-A1 (CA)
Title: Method and software for mobile data collection having managed workflow
Inventor: SANDLER IGOR
IPC: G06Q10/06
Filed: 2005-06-14
Abstract: A computerized method for collecting information on geo-spatially distributed assets.      The method includes managed workflow so that work crews are automatically informed of the work that needs to be done and can report back to management when the work is completed. Mobile workers use a network-disconnected mobile computing device for data collection that includes a GPS receiver for use in generating a map showing the user's position in relation to the asset. An asset attribute database having a vertical database schema permits live-entry of the collected data without the need for confirmation, thereby speeding data entry and reducing the likelihood of data loss in the event of power failure, etc. The vertical database schema also permits data collection forms to be changed without updating the underlying database structure.  The vertical database schema is converted to a relational database schema for management reporting purposes.
Patent CA-2510442-A1 (CA)
Title: Partial oxidation reformer-reforming exchanger arrangement
Inventor: MANN DAVID P
IPC: B01J8/06
Filed: 2004-03-16
Abstract: Low-energy hydrogen production is disclosed. A reforming exchanger is placed in parallel with a partial oxidation reactor in a new hydrogen plant with improved efficiency and reduced steam export, or in an existing hydrogen plant where the hydrogen capacity can be increased by as much as 20-30 percent with reduced export of steam from the hydrogen plant.
Patent CA-2513704-A1 (CA)
Inventor: KAEDING-KOPPERS ANNETT
IPC: B65D77/20
Filed: 2004-01-19
Abstract: The invention relates to a reclosable packaging comprising a packaging tray that is made of a multilayer film and a lid which is made of a multilayer film. The tray and the lid are joined together in the edge area of the packaging tray via a sealing seam. The multilayer film of the packaging tray or lid is provided with a contact adhesive layer and a migration barrier layer having a thickness of preferably < 2 ~m.
Patent CA-2513737-A1 (CA)
Inventor: ISHINO HIROSHIGE
IPC: C07C41/06
Filed: 2004-01-20
Abstract: A process for the production of ethers, characterized by reacting a conjugated diene with an alcohol via telomerization in the presence of a catalyst composition comprising a palladium compound, an isocyanide represented by the general (I): R1R2R3CNC (I) and a base represented by the general formula (II):  M(OR4)n (II) [in the formulae, each symbol is as defined in the description].  According to the process, ethers can be industrially advantageously produced by telomerization of a conjugated diene with an alcohol.
Patent CA-2523941-A1 (CA)
Inventor: SCHRAMM JOHN B
IPC: A61B10/02
Filed: 2005-10-20
Abstract: An apparatus for the automated and facilitated handling and operation of a biopsy needle system, having a first needle component and a second needle component. The first and second needles are provided with first and second handles, respectively, which are fitted into first and second yokes of the apparatus. The apparatus is configured to maintain the first and second needles in a first position, during insertion of the biopsy needle point into the tissue being sampled. The apparatus is further configured to forwardly move the first and second needles into subsequent positions, respectively, in rapid, automated succession so as to segment and enclose a tissue sample, which may be tested after removal of the biopsy needle system from the tissue. A tissue sample inspection feature permits facilitated repositioning and maintenance of the first needle relative to the second needle after retrieval of the tissue sample to, in turn, enable inspection of the retrieved tissue sample without removal of either needle from the apparatus. The apparatus is further configured so as to be actuatable from positions adjacent the front or the rear of the apparatus housing. A safety lock feature is provided, which prevents inadvertent cocking motions, when the apparatus is actuated by either its rear or forward firing buttons.
Patent CA-2525696-A1 (CA)
Inventor: HIROTA JUNJI
IPC: C12N5/078
Filed: 2003-10-31
Abstract: Analysis of substance capable of binding with inositol-1,4,5-triphosphate (IP3) receptor (IP3R), preferably with a regulation domain of IP3R; analysis of the function of IP3R; and establishing of a method of treatment or diagnosis for various malfunctions and diseases associated with IP3R. In particular, control of the activity of intracellular Ca2+ release. More specifically, a regulator for the activity of inositol-1,4,5-triphosphate (IP3) receptor (IP3R), comprised of carbonic anhydrase related protein (CARP);  a control agent for intracellular calcium release, comprised of carbonic anhydrase related protein (CARP); and a method of control therewith.
Patent CA-2529715-A1 (CA)
Title: Acoustic touch sensor with low-profile diffractive grating transducer assembly
Inventor: TSUMURA MASAHIRO
IPC: G06F3/033
Filed: 2004-05-26
Abstract: A touch sensor having an acoustic substrate, an acoustic transducer, and an acoustically diffractive grating is provided. The grating is disposed between the transducer and the substrate, so that acoustic energy from the transducer is coupled to an acoustic wave propagating along the surface of the substrate.  If used in a display device, the combination of the transducer and grating may provide a low profile that allows the assembly to be more easily placed between the acoustic substrate and a bezel placed in front of the substrate.  No acoustic components need be mounted on the rear surface of the substrate, allowing the acoustic substrate to be formed on the front surface of the display device.
Patent CA-2529938-A1 (CA)
Title: Dipeptide transglutaminase inhibitors and methods of using the same
Inventor: GRIFFIN MARTIN
IPC: C07K5/06
Filed: 2004-06-16
Abstract: The present invention relates to novel compounds of Formula (I) wherein ~X~  represents an amino acid group, ~n~ is an integer between 1 and 4, ~R1~  represents benzyl, t-butyl or 9-fluorenylmethyl and ~R2~ represents a tetramethylmercaptoimidazole derivative or -S+R3R4, wherein R3 and R4 each independently represent lower alkyl, or a pharmaceutically and/or veterinarily acceptable derivative thereof. The present invention further relates to pharmaceutical formulations of said compound and the use thereof in the preparation of a medicament for inhibiting diseases in which transglutaminase has been implicated. Advantageously, the medicament is for treating fibrosis, scarring and/or cancer. Additionally, the invention relates to a method of inhibiting autoimmune diseases such as coeliac disease, neurodegeneration and chronic inflammatory diseases (e.g. of the joints including rheumatoid arthritis and osteoarthritis in a subject). The invention further relates to a method for preventing or treating rejection of a transplanted organ.
Patent CA-2535556-A1 (CA)
Inventor: WATERMANN MARKUS
IPC: A61K6/884
Filed: 2004-08-11
Abstract: The present invention is directed to dental compositions that can be used as adhesives for bonding a dental material to a dental structure surface and/or as a dental restorative material. The dental composition is preferably applied to a dental structure surface under conditions effective to etch the dental structure surface.
Patent CA-2535777-A1 (CA)
Title: Method and apparatus for pattern identification in diploid dna sequence data
Inventor: SUN DAKE
IPC: G16B30/10
Filed: 2004-03-05
Abstract: This invention provides methods for identifying mutations and methylation patterns in diploid DNA sequence signal data. In particular, the invention provides methods for (1) obtaining two parental allele sequences from diploid DNA sequence signal data, (2) identifying the mutation and haplotype patterns in the two parental allele sequences, (3) assigning likelihood scores for the mutations thus identified, and (4) identifying patterns of methylation.
Patent CA-2539276-A1 (CA)
Title: Methods of preventing or treating recurrence of myocardial infarction
Inventor: HELGADOTTIR ANNA
IPC: A61K31/198
Filed: 2004-09-17
Abstract: Linkage of myocardial infarction (MI) with a locus on chromosome 12q23 is disclosed. In particular, the LTA4H gene within this locus is shown by association analysis to be a susceptibility gene for MI. Methods for preventing and/or treating the recurrence of MI, in particular are described.
Patent CA-2541134-A1 (CA)
Inventor: BOIS HENRI
IPC: B65D33/24
Filed: 2006-03-28
Abstract: La présente invention concerne un sachet d'emballage comprenant des moyens de fermeture (40) à base de profilés comportant des voiles qui portent des moyens complémentaires, caractérisé par le fait que les voiles des profilés sont d'une première couleur et que les films composant les parois (14) du sachet d'une part sont opaque et d'une seconde couleur différente de celle des voiles des profilés, au moins au voisinage de ces derniers et d'autre part recouvrent l'essentiel de ces voiles pour ne laisser apparaître à l'extérieur du sachet qu'un mince liseré continu de la première couleur s'étendant tout le long des moyens de fermeture.
Patent CA-2541166-A1 (CA)
Title: Site-specific incorporation of redox active amino acids into proteins
Inventor: ALFONTA LITAL
IPC: C12P21/06
Filed: 2004-10-13
Abstract: Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal tRNAs, orthogonal aminoacyl-tRNA  synthetases, and orthogonal pairs of tRNAs/synthetases, which incorporate redox active amino acids into proteins are provided. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins with redox active amino acids using these orthogonal pairs.
Patent CA-2544357-A1 (CA)
Title: Tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
Inventor: PFRENGLE WALDEMAR
IPC: A61K31/46
Filed: 2004-10-29
Abstract: The invention relates to novel tiotropium salts, methods for the production thereof, pharmaceutical formulations containing the same, and the use thereof for producing a medicament that is used for the treatment of respiratory diseases, especially COPD (chronic obstructive pulmonary disease) and asthma.
Patent CA-2546873-A1 (CA)
Inventor: SCHROTZ-KING PETRA
IPC: G01N33/569
Filed: 2004-11-19
Abstract: The present invention relates to surface-located polypeptides of Campylobacter jejuni and their use in vaccination against Campylobacter. The invention furthermore relates to the use in vaccination of polynucleotides, expression vectors, recombinant viruses or recombinant cells expressing these surface-located polypeptides. Moreover, the invention relates to the use of antibodies against the surface-located polypeptides for anti-Campylobacter therapy. Finally, methods for detection of Campylobacter and for identifying anti-Campylobacter agents through the surface-located polypeptides is disclosed.
Patent CA-2547568-A1 (CA)
Title: Coral purification method and coral thus obtained
Inventor: SCHMITTHAEUSLER ROLAND
IPC: A61L27/36
Filed: 2004-12-06
Abstract: The invention relates to a method of extracting organic substances from coral, consisting in treating the coral with a fluid or a mixture of fluids in the supercritical state, without altering the crystalline structure of said coral, at a temperature of less than 270 ~C and at a pressure much greater than the critical pressure of the fluid or mixture of fluids, for example, of the order of at least three times or, preferably, at least five times greater than said critical pressure. The invention also relates to the coral obtained using said method and to bone substitutes produced therefrom.
Patent CA-2549009-A1 (CA)
Title: Opioid receptor antagonists
Inventor: BENESH DANA RAE
IPC: C07D213/80
Filed: 2004-12-06
Abstract: A compound of the formula (I) wherein the variables X1 to X5, R1 to R7 including R3', E, q, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.
Patent CA-2549543-A1 (CA)
Title: Method and apparatus for liquid chromatography automated sample loading
Inventor: ROENNEBURG LUKE
IPC: G01N35/10
Filed: 2004-12-17
Abstract: A method for automated loading of liquid sample to a liquid chromatography testing device is provided including installing a disposable tip on a probe, moving the probe with an automated liquid handler to a loading position proximate to a sample, and drawing a sample into the disposable tip. The probe is then moved to an injection position proximate an injection port, and the sample is injected from the disposable tip into the injection port. Also provided are the novel injection ports. After injection of the sample, the disposable tip is then removed from the probe. These steps may be repeated a plurality of times to sequentially load a plurality of samples. An exemplary method of the invention is directed to use with a liquid chromatography apparatus. An apparatus for assisting in the removal of the disposable tip is also provided.
Patent CA-2550183-A1 (CA)
Title: Closure with selectable dispensing orifices
Inventor: MENGEU GARY L
IPC: B65D1/32
Filed: 2006-06-14
Abstract: A dispenser for dispensing a viscous material in a selected one of a multiplicity of configurations comprises a container having a squeezable body and neck with a discharge opening at its upper end. Engaged with the container is a closure body of generally circular cross section with a top wall and skirt. The top wall has a post with a discharge passage therethrough aligned with the neck discharge opening. A generally circular rotating disc is rotatably disposed on the closure body top wall and has a central hub seating said post. The post has an aperture alignable with the hub discharge passage for passage of viscous material therethrough. The disc has a multiplicity of flow openings spaced about the disc in a circular array and represents a multiplicity of configurations. The disc also has a multiplicity of flow channels extending from the post to the flow openings of the disc, and it is rotatable to align the flow channel of the selected flow opening with the aperture in the post to permit viscous material to flow through the neck and top wall of the closure body into the post and outwardly in flow channels to a selected disc discharge opening.
Patent CA-2552590-A1 (CA)
Inventor: LO KIN-MING
IPC: A61P35/00
Filed: 2005-01-05
Abstract: The invention provides a compound comprising a target specific portion and an effector portion wherein the target specific portion comprises or consists of a monoclonal antibody having specificity for oncofoetal fibronectin, or a fragment or variant thereof which retains the antigen binding specificity of the parent monoclonal antibody and the effector portion comprises or consists of interleukin-12, or a functional fragment or variant thereof, characterised in the monoclonal antibody having specificity for oncofoetal fibronectin binds to a region of oncofoetal fibronectin other than the ED-B region. The invention further provides nucleic acids encoding the compounds of the invention, and the use of such compounds in medicine, e.g. in the treatment of cancer.
Patent CA-2552739-A1 (CA)
Inventor: BONNAUD THIERRY
IPC: A61K31/407
Filed: 2005-01-06
Abstract: A compound of the formula (II) wherein one of R1 and R2 is halo and the other is H or halo; R3 is C1-C4 straight or branched chain, optionally fluorinated, alkyl; R4 is H; or R3 together with R4 and the adjoining backbone carbon defines: a spiro-C5-C7 cycloalkyl, optionally substituted with 1 to 3 substituents selected from halo, hydroxyl, C1-C4 alkyl or C1-C4 haloalkyl; or optionally bridged with a methylene group; or a C4-C6 saturated heterocycle having a hetero atom selected from O, NRa, S, S(=O)2 ; where Ra is H, C1-C4 alkyl or CH3C(=O); R5 is independently selected from H or methyl; E is -C(=O)-, -S(=O)m-, -NR5S(=O)m-, -NR5C(=O)-, -OC(=O)-, R6 is a stable, optionally substituted, monocyclic or bicyclic, carbocycle or hetorocycle; m is independently 0,1 or 2; are inhibitors of cathepsin K and useful in the treatment or prophylaxis of osteoporosis.
Patent CA-2553691-A1 (CA)
Title: Application-based value billing in a wireless subscriber network
Inventor: OLIVER MITCHELL B
IPC: H04W4/24
Filed: 2005-01-20
Abstract: Systems and methods for application-based billing in a wireless subscriber billing system are disclosed. A wireless client device can generate and transmit a billing request to the billing system. The billing system generates a validation response to the billing request and transmits the validation response to the client device. The validation response can be processed by the client device to enable a service linked to the billing request.
Patent CA-2554663-A1 (CA)
Title: Tower for a wind turbine, prefabricated metal wall part for use in a tower for a wind turbine and method for constructing a tower for a wind turbine
Inventor: SPORTEL HEIKO
IPC: F03D1/00
Filed: 2005-01-14
Abstract: The invention relates to a tower for a wind turbine wherein the tower has an exterior side and an interior side and wherein the tower is at least partly composed of prefabricated metal wall parts characterised in that each wall part comprises an essentially quadrangular portion having an outwardly facing surface in the direction of the exterior of the tower and an inwardly facing surface in the direction of the interior of the tower, said portion having a top edge, a bottom edge, a first side edge and a second side edge, wherein the first side edge is provided with a first flange along at least part of the length of the first side edge and wherein the second side edge is provided with a second flange along at least part of the length of the second side edge.
Patent CA-2554978-A1 (CA)
Inventor: BLUESTONE JEFFREY A
IPC: A61K39/00
Filed: 2005-02-04
Abstract: The invention provides methods for treating autoimmunity and for reestablishing tolerance. The methods involve the coadministration of anti-CD3 antibodies and self-antigens. The coadministration has the potential to provide a synergistic effect of protecting or reducing autoaggressive immune processes and/or of reestablishing tolerance towards self-antigens. An underlying rationale behind the methods is that the administration of self-antigens together with anti-CD3 antibodies can alter the response to those self-antigens and prevent progression of autoimmunity. By rechallenging with the autoantigens and stimulating the non-pathogenic response, the blockade of the autoimmune process can be maintained. Preclinical evidence provided herein shows that the combination of anti-CD3 and autoantigen is synergistic in reversing autoimmune diabetes, and therefore, suggests that combination therapy of anti-CD3 and self-antigen may provide synergistic protection in reversing other autoimmune disorders.
Patent CA-2557971-A1 (CA)
Title: System and method for session provision
Inventor: VESIKIVI PETRI
IPC: H04K1/00
Filed: 2005-02-16
Abstract: Systems and methods applicable, for instance, in session provision. A node and/or other computer may, for example, dispatch to one or more servers and/or the like a message including a provided value and a value obtained, for instance, from a storage element. The one or more servers and/or the like may, for example, having performed various registration checks, act to create a token for provision to the node and/or other computer. Messages sent by the node and/or other computer including the token could, for instance, be considered to be associated with a session.
Patent CA-2558308-A1 (CA)
Title: Method and apparatus for characterising a three phase transformer using a single phase power supply
Inventor: FAWCETT TIMOTHY JAMES
IPC: G01R31/72
Filed: 2005-03-03
Abstract: A method and apparatus for characterising a three phase transformer (3) using a single phase power supply (1). Pairs of input terminals (H0-H3) of the transformer are sequentially energised for each energisation and the voltage between pairs of output terminals (x0-x3) of the transformer are measured.  Measured voltages are processed in order to characterise the winding configuration of the transformer. Either simultaneously or subsequently the presence of neutrals on the primary and/or secondary side of the transformer are identified to enable the winding configuration to be further characterised. Subsequently any phase displacement of the transformer is determined. The apparatus comprises means (2) for selectively applying a single phase power supply (1) to pairs of terminals (H0-H3) on the transformer (3) and for measuring voltages between pairs of terminals (x0-x3) of the transformer and for measuring phase difference between the primary and secondary sides of the transformer all under automatic control of a control means (13) which includes a processing means to process measured voltages and phase differences in order to characterise the transformer.